- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03267043
Family Nurture Intervention in the NICU at The Valley Hospital
The purpose of this study is to compare neurodevelopment and activity in infants born preterm (25 to 34 1/7 weeks gestational age (GA)) receiving Standard Care (SC) or Family Nurture Intervention (FNI) in the neonatal intensive care unit (NICU).
The investigators hypothesize that FNI will improve: i) neonatal electroencephalographic activity ii) maternal caregiving and wellbeing (psychological and physiological, and iii) infant behavior and neurodevelopment at 18 months corrected age (CA).
The two-phase effectiveness study aims to:
- Phase 1 - Examine the existing Standard Care Approximately 35 infants and their mothers
- Phase 2 - Examine effectiveness by implementing FNI unit-wide so that every baby receives the intervention Approximately 35 infants and their mothers
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study aims to build upon the findings of the earlier randomized controlled trial (RCT) conducted at the Columbia University Medical Center (CUMC) comparing effects, both physiological and emotional, of the current standard method of encouraging contact between mothers and their babies in the NICU with the more specific approach of Family Nurture Intervention (FNI). In addition to receiving standard care, NICU families assigned to FNI received added intervention that focused on supporting the parents and facilitating emotional connection between mother and infant during the infant's NICU stay.
The investigators wish to conduct an effectiveness trial to evaluate if the family nurture intervention's findings can be replicated on a unit-wide level. This effectiveness trial will take place over two parts. There will be two groups; standard care (SC) and intervention (FNI). Phase 1 of the effectiveness study will evaluate the standard care (SC) group in the unit as a baseline measurement and point of comparison to determine if unit-wide FNI reproduces its prior findings (Phase 2). The standard care group (Phase 1) will receive the current standard of care in the NICU. In Phase 2, FNI will be implemented unit-wide, but infants born between 26 weeks and 0 days to 33 weeks 6 days gestation will be eligible to be enrolled into the study. In addition to receiving standard care, patients enrolled during phase 2 will receive added interventions from the trained FNI nursing staff. These added interventions will include supporting the parents and facilitating contact between mother and infant during their infant's NICU stay.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New Jersey
-
Ridgewood, New Jersey, United States, 07450
- The Valley Hospital
-
-
New York
-
New York, New York, United States, 10032
- Morgan Stanley Children's Hospital of New York (MSCHONY)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
For the Standard Care and FNI Groups
Inclusion Criteria:
- infant is between 26 and 33 6/7 weeks gestational age upon admission
- infant is a singleton or twin
Exclusion Criteria:
- infant's attending physician does not recommend enrollment in the study
- severe congenital anomalies including chromosomal anomalies
- ultrasound evidence of large parenchymal hemorrhagic infarction (>2 cm, intraventricular hemorrhage grade 3 or 4)
- infant cardiac anomalies
- mother has known history of substance abuse, severe psychiatric illness or psychosis
- status of enrolled subject changes and subject now falls into exclusion criteria
- mother and/or infant has a medical condition that precludes intervention components
- mother and/or infant has a contagion that endangers other participants in the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Sequential Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Standard Care
Participants enrolled in Phase 1 will be receiving the current standard of care in the NICU at The Valley Hospital.
|
Established routine care provided on the NICU floor by specially trained health care professionals.
Other Names:
|
Experimental: Family Nurture Intervention (FNI)
Participants enrolled in Phase 2 will be receiving family nurture intervention (FNI) that focuses on supporting the parents and facilitating emotional connection between mother and infant during the infant's NICU stay.
|
Subjects will be guided by the nursing staff through an enhanced program of mother/infant interactions, which include skin-to-skin holding.
Other Names:
|
Active Comparator: Standard Care - Case Studies
Participants enrolled as case studies in Phase 1 will be receiving the current standard of care in the NICU at The Valley Hospital.
These participants will be those who fall outside the inclusion criteria.
|
Established routine care provided on the NICU floor by specially trained health care professionals.
Other Names:
|
Experimental: FNI - Case Studies
Participants enrolled in Phase 2 will be receiving family nurture intervention (FNI) that focuses on supporting the parents and facilitating emotional connection between mother and infant during the infant's NICU stay.
These fall outside the inclusion criteria but act as a comparator to the case studies of Phase 1.
|
Subjects will be guided by the nursing staff through an enhanced program of mother/infant interactions, which include skin-to-skin holding.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
EEG Power in the frontal polar region
Time Frame: Up to 41 weeks gestational age
|
Measured in microvolts (µV)^2 for infants.
|
Up to 41 weeks gestational age
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
EEG Coherence in the left frontal polar to right frontal polar region
Time Frame: Up to 41 weeks gestational age
|
Coherence is a number between 0-1, generated by looking at the similarity/differences in activity between brain regions through analysis of EEG.
|
Up to 41 weeks gestational age
|
CES-D Score
Time Frame: Up to 18 months
|
To examine maternal depression, the Center for Epidemiologic Studies Depression Scale (CES-D) is a 20 item self-report inventory designed to assess current but nonspecific distress rather than clinically diagnosed depression.
It is the most frequently used measure in the field of infant research and maternal depression.
Items probe for depressive symptoms and attitudes within the past week.
|
Up to 18 months
|
State-Trait Anxiety Inventory (STAI) Score
Time Frame: Up to 18 months
|
To examine Maternal Anxiety, the State-Trait Anxiety Inventory (STAI) comprises 2 separate self-report scales of 20 items each that measure state and trait anxiety.
The S-Anxiety Scale (measuring state), has been found to be a sensitive indicator of changes in transitory anxiety experienced by patients in counseling, psychotherapy, and behavior-modification programs, and has been used to assess the level of anxiety induced by unavoidable real-life stressors.
The T-Anxiety scale has proven useful for identifying persons who differ in motivation or drive level.
The STAI has been used in studies examining parents of hospitalized children, the transition to a maternal role, perception of illness severity in infants, and maternal anxiety during pregnancy and fetal attachment.
|
Up to 18 months
|
Neurobehavioral Assessments of Infants - Bayley Scales or Infant and Toddler Development, Bayley III
Time Frame: Up to 18 months
|
At the 18 month corrected age follow-up, infants are administered the Bayley Scales of Infant and Toddler Development, Bayley III consisting of three developmental domains: Cognitive, Language (receptive/expressive) and Motor (fine/gross). For each domain, a composite score is provided and is scaled to a mean score of 100 and a standard deviation of 15. A child will receive 1 point for every item successfully completed. The administration of each section will end if the child received 0 points on 5 consecutive items. Scores <70 indicate significant developmental delays and scores <80 indicate mild to moderate developmental delays. Cognitive Scale - comprised of 91 items Language Scale - comprised of 97 items Motor Scale - comprised of 138 items |
Up to 18 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Welch Emotional Connection Scale
Time Frame: Up to 18 months
|
To examine Mother-Infant Emotional Connection, this is a brief 4-item assessment requiring 5 minutes or less, which assesses the character of the relationship between study mothers and infants.
It is filled out by study staff who rate mothers and infants in a dyadic interaction on their attraction, their vocal communication, facial expressiveness, and sensitivity and responsivity towards each other.
|
Up to 18 months
|
Child Behavior Checklist Score
Time Frame: Up to 18 months
|
The Child Behavior Checklist (CBCL) is a device by which parents rate their child's problem behaviors and competencies.
The CBCL can also be used to measure a child's change in behavior over time or following a treatment.
The CBCL consists of 100 items.
This will be administered at the 18 Months CA Follow-Up.
|
Up to 18 months
|
Modified Checklist for Autism in Toddlers (M-CHAT) Score
Time Frame: Up to 18 months
|
The M-CHAT is a questionnaire validated for screening toddlers to assess risk for autism spectrum disorders (ASD).
It is a 23 yes/no item questionnaire administered to the mother which can be scored in less than 2 minutes.
This will be administered at the 18 Month CA Follow-Up.
|
Up to 18 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- AAAR4899
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Premature Birth
-
Shaare Zedek Medical CenterTerminatedPremature Birth of NewbornIsrael
-
University of VirginiaCompletedPremature Birth of NewbornUnited States
-
Case Western Reserve UniversityCompleted
-
University of California, San FranciscoUniversity of California, San Diego; University of California, Los Angeles; Kaiser...CompletedPremature Birth of NewbornUnited States
-
Universitaire Ziekenhuizen KU LeuvenKU LeuvenUnknownPremature Birth of NewbornBelgium
-
Universidad Complutense de MadridCompletedPremature Birth of Newborn
-
Indiana UniversityCompletedPremature LaborUnited States
-
Washington University School of MedicineUniversity of Southern CaliforniaCompletedPremature Birth of NewbornUnited States
-
Vestre Viken Hospital TrustHaukeland University HospitalActive, not recruiting
-
University of ArkansasCompletedPremature Birth of NewbornUnited States
Clinical Trials on Standard Care
-
Evandro Chagas Institute of Clinical ResearchAlejandro Marcel Hasslocher Moreno, MD MSc PhD student; Andrea Costa, MD PhD; Andrea Silvestre de Sousa, MD PhD and other collaboratorsUnknownChagas Heart DiseaseBrazil
-
Neuroscience Trials AustraliaNational Institute for Health Research, United Kingdom; Northern Ireland Chest... and other collaboratorsCompleted
-
University of OklahomaNational Cancer Institute (NCI)CompletedSmoking CessationUnited States
-
Avita MedicalNAMSACompletedVenous Leg UlcersUnited Kingdom, France
-
University of MichiganCompleted
-
University of OklahomaCompletedTobacco Cessation | Tobacco Use | Tobacco Smoking | Smoking Cessation Financial Incentives | Socioeconomic Status | Contingency ManagementUnited States
-
University of OklahomaEnrolling by invitationTobacco Cessation | Tobacco Use | Tobacco Smoking | Smoking Cessation Financial Incentives | Socioeconomic Status | Contingency Management | PregnancyUnited States
-
Institut de Cancérologie de LorraineTerminatedBreast CancerFrance
-
Indonesia UniversityCompletedCovid19 | AcupunctureIndonesia
-
brett rasmussenCompleted